MedPage Today on MSN
Obesity Drops in Adults; Wegovy's Heart Protection; Women Turn to Testosterone
The obesity rate for adults in the U.S. dropped to 37% in 2025 after peaking at 39.9% in 2022, but diabetes has reached an ...
Somehow, it’s becoming even harder to get a GLP-1.
Novo Nordisk today announced plans to present 11 abstracts at the 76th Annual American Association for the Study of Liver ...
This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives ...
BMI is a measure of body weight relative to height. The goal for most people is to have a BMI that’s over 18 and under 25.
Insider buys can be a telltale sign of a turnaround, as these investments give you a window into where management stands with ...
The 44-year-old comedian — who has shed 'at least 40lbs' with help from GLP-1 weight loss drug Mounjaro — showed off her ...
Until recently, GLP -1s, a powerful new class of weight-loss drugs, were confined mostly to rich countries. Yet the World ...
Karen McGonigal, 53, died days after she was illegally administered a dose of semaglutide - the powerful ingredient behind Ozempic and Wegovy - in May.
Doctors warn that weight-loss supplements can interact with other medications and may not be tested or standardized, so people should be careful when taking them.
According to the Gallup National Health and Well-Being Index, America’s adult obesity rate has fallen to 37% in 2025, down ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results